✦ LIBER ✦

Carcinoma of the Head and Neck: A 5- to 20-Year Experience With Preoperative Chemotherapy, Uncompromised Surgery, and Selective Radiotherapy

✍ Scribed by John M. Loré; Sol Kaufman; Nan Sundquist; Kandala K. Chary

Book ID: 111771236
Publisher: Springer
Year: 2003
Tongue: English
Weight: 189 KB
Volume: 10
Category: Article
ISSN: 1068-9265
DOI: 10.1245/aso.2003.06.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved survival with preoperative chem

Improved survival with preoperative chemotherapy followed by resection uncompromised by tumor response for advanced squamous cell carcinoma of the Head and Neck

✍ John M. Loré Jr.; Ernesto Diaz-Ordaz; Monica Spaulding; Kandala Chary; Sol Kaufm 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 777 KB

Simultaneous radio- and chemotherapy for

Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital

✍ M. Langenberg; C.H.J. Terhaard; G.J. Hordijk; R.J.J. van Es; E.E. Voest; A. de G 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Treatment complications after sequential

Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck

✍ Marshall R. Posner; Ralph R. Weichselbaum; Thomas J. Fitzgerald; John R. Clark; 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 878 KB

Docetaxel, cisplatin, and 5-fluorouracil

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck : The Dana Farber Cancer Institute experience

✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime

Induction chemotherapy followed by concu

Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: Final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up

✍ Alexander D. Rapidis; Miltiades Trichas; Elias Stavrinidis; Alexandra Roupakia; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Nimotuzumab provides survival benefit to

Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients

✍ Reddy, B.K.M.; Lokesh, V.; Vidyasagar, M.S.; Shenoy, K.; Babu, K.G.; Shenoy, A.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 858 KB